Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Definition

2. Executive Summary

3. Impact of COVID-19 on Global Autoimmune Disorder Drug Delivery Devices Market

4. Global Autoimmune Disorder Drug Delivery Devices Market Regulations & Policy

5. Global Autoimmune Disorder Drug Delivery Devices Market Trends & Insights

6. Global Autoimmune Disorder Drug Delivery Devices Market Dynamics
6.1. Drivers
6.2. Challenges
6.3. Impact Analysis

7. Global Autoimmune Disorder Drug Delivery Devices Market Hotspots & Opportunities

8. Global Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016- 2026F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Indication
8.2.1.1. Psoriasis
8.2.1.2. Rheumatoid Arthritis
8.2.1.3. Multiple Sclerosis
8.2.1.4. Inflammatory Bowel Diseases
8.2.1.5. Systemic Lupus Erythematosus
8.2.1.6. Diabetes Mellitus
8.2.1.7. Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
8.2.2. By Product Type
8.2.2.1. Pen-Injectors
8.2.2.2. Auto-Injectors
8.2.2.3. Pre-Filled Syringes
8.2.2.4. Vials
8.2.3. By Manufacturing Type
8.2.3.1. In-House Manufacturing
8.2.3.2. Outsourced Manufacturing
8.2.4. By Region
8.2.4.1. North America
8.2.4.2. South America
8.2.4.3. Europe
8.2.4.4. Asia Pacific
8.2.4.5. Middle East and Africa
8.2.5. By Competitors
8.2.5.1. Competition Characteristics
8.2.5.2. Market Share & Analysis
8.2.5.3. Competitive Matrix

9. North America Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Indication
9.2.2. By Product Type
9.2.3. By Manufacturing Type
9.2.4. By Country
9.2.4.1. The U.S.
9.2.4.2. Canada
9.2.4.3. Mexico
9.3. The U.S. Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
9.3.1. Market Size & Analysis
9.3.1.1. By Revenues
9.3.2. Market Share & Analysis
9.3.2.1. By Indication
9.4. Canada Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
9.4.1. Market Size & Analysis
9.4.1.1. By Revenues
9.4.2. Market Share & Analysis
9.4.2.1. By Indication
9.5. Mexico Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
9.5.1. Market Size & Analysis
9.5.1.1. By Revenues
9.5.2. Market Share & Analysis
9.5.2.1. By Indication

10. South America Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Indication
10.2.2. By Product Type
10.2.3. By Manufacturing Type
10.2.4. By Country
10.2.4.1. Brazil
10.2.4.2. Others
10.3. Brazil Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
10.3.1. Market Size & Analysis
10.3.1.1. By Revenues
10.3.2. Market Share & Analysis
10.3.2.1. By Indication

11. Europe Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.1. Market Size & Analysis
11.1.1. By Revenues
11.2. Market Share & Analysis
11.2.1. By Indication
11.2.2. By Product Type
11.2.3. By Manufacturing Type
11.2.4. By Country
11.2.4.1. The U.K.
11.2.4.2. Germany
11.2.4.3. France
11.2.4.4. Italy
11.2.4.5. Spain
11.2.4.6. Others
11.3. The U.K. Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.3.1. Market Size & Analysis
11.3.1.1. By Revenues
11.3.2. Market Share & Analysis
11.3.2.1. By Indication
11.4. Germany Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.4.1. Market Size & Analysis
11.4.1.1. By Revenues
11.4.2. Market Share & Analysis
11.4.2.1. By Indication
11.5. France Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.5.1. Market Size & Analysis
11.5.1.1. By Revenues
11.5.2. Market Share & Analysis
11.5.2.1. By Indication
11.6. Italy Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.6.1. Market Size & Analysis
11.6.1.1. By Revenues
11.6.2. Market Share & Analysis
11.6.2.1. By Indication
11.7. Spain Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
11.7.1. Market Size & Analysis
11.7.1.1. By Revenues
11.7.2. Market Share & Analysis
11.7.2.1. By Indication

12. Asia-Pacific Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.1. Market Size & Analysis
12.1.1. By Revenues
12.2. Market Share & Analysis
12.2.1. By Indication
12.2.2. By Product Type
12.2.3. By Manufacturing Type
12.2.4. By Country
12.2.4.1. China
12.2.4.2. India
12.2.4.3. Japan
12.2.4.4. South Korea
12.2.4.5. Australia
12.2.4.6. Others
12.3. China Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. By Revenues
12.3.2. Market Share & Analysis
12.3.2.1. By Indication
12.4. India Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. By Revenues
12.4.2. Market Share & Analysis
12.4.2.1. By Indication
12.5. Japan Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.5.1. Market Size & Analysis
12.5.1.1. By Revenues
12.5.2. Market Share & Analysis
12.5.2.1. By Indication
12.6. South Korea Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.6.1. Market Size & Analysis
12.6.1.1. By Revenues
12.6.2. Market Share & Analysis
12.6.2.1. By Indication
12.7. Australia Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
12.7.1. Market Size & Analysis
12.7.1.1. By Revenues
12.7.2. Market Share & Analysis
12.7.2.1. By Indication

13. Middle East and Africa Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
13.1. Market Size & Analysis
13.1.1. By Revenues
13.2. Market Share & Analysis
13.2.1. By Indication
13.2.2. By Product Type
13.2.3. By Manufacturing Type
13.2.4. By Country
13.2.4.1. UAE
13.2.4.2. Saudi Arabia
13.2.4.3. South Africa
13.2.4.4. Others
13.3. UAE Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. By Revenues
13.3.2. Market Share & Analysis
13.3.2.1. By Indication
13.4. Saudi Arabia Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
13.4.1. Market Size & Analysis
13.4.1.1. By Revenues
13.4.2. Market Share & Analysis
13.4.2.1. By Indication
13.5. South Africa Autoimmune Disorder Drug Delivery Devices Market Outlook, 2016-2026F
13.5.1. Market Size & Analysis
13.5.1.1. By Revenues
13.5.2. Market Share & Analysis
13.5.2.1. By Indication
14. Key Strategic Imperatives for Success and Growth
15. Competition Outlook (Whichever Applicable)
15.1. Competition Matrix
15.1.1. Brand Specialization
15.1.2. Target Markets
15.1.3. Target End Users
15.1.4. Research & Development
15.1.5. Strategic Alliances
15.1.6. Strategic Initiatives
15.2. Company Profiles
15.2.1. Amgen Inc.
15.2.2. AbbVie Inc.
15.2.3. Bayer AG
15.2.4. Biogen Inc.
15.2.5. Eli Lilly and Company
15.2.6. Bristol-Myers Squibb Company
15.2.7. F. Hoffmann-La Roche AG
15.2.8. GlaxoSmithKline plc
15.2.9. Johnson & Johnson Services, Inc.
15.2.10. The Merck Group
15.2.11. Novartis International AG
15.2.12. Sanofi S.A.
15.2.13. Teva Pharmaceutical Industries Ltd.
15.2.14. UCB Pharma SA.
16. Disclaimer